News

Medtronic Diabetes Recalls Infusion Sets


 

Medtronic Diabetes is recalling its Quick-set infusion sets that have lot numbers starting with the number 8 and reference numbers MMT-396 through MMT-399.

The “Lot 8” Quick-set infusion sets, used with MiniMed Paradigm insulin pumps, are being recalled because they were manufactured with an added lubricant that was clogging the vents in approximately 2% of the sets from that lot, preventing the insulin pump from venting properly. This could potentially result in too much or too little insulin being delivered and may lead to serious injury or death.

Customers should stop using Lot 8 Quick-set infusion sets right away. Medtronic is providing replacement infusion sets to customers at no additional charge.

Limited quantities of Lot 8 infusion sets have been distributed in the Bahamas, Bermuda, Brazil, Canada, Ecuador, El Salvador, Germany, Kuwait, Mexico, Paraguay, Turkey, and the United Kingdom. In Canada, customers who have received the sets from Medtronic Diabetes will be contacted. Canadian customers who have questions or concerns should call Canada's customer service line at 1-800-284-4416 for more information.

No other Medtronic infusion sets are affected by this recall. Customers may use any other Paradigm infusion sets they have available and have been trained on (including Quick-sets other than Lot 8, and Silhouette, Sure-T, Sof-set, or Polyfin infusion sets), the company said online.

Recommended Reading

Part D 'Doughnut Hole' Affects Quarter of Diabetic Patients
MDedge Family Medicine
Undiagnosed Diabetes May Affect 3.8% of Adults
MDedge Family Medicine
Expert Proposes Lower Normal Range for TSH
MDedge Family Medicine
Fenofibrate May Prevent Amputation in Type 2
MDedge Family Medicine
Ultrasound Helpful in Thyroid Cancer Follow-Up
MDedge Family Medicine
Diabetes Increases Atrial Fibrillation Risk by 18%
MDedge Family Medicine
Mortality Found No Higher With Rosiglitazone
MDedge Family Medicine
Medical Therapy, Revascularization Equal in Type 2 Diabetics
MDedge Family Medicine
Scoring Tools Predict Progression to Diabetes : One CDC-developed system doesn't even require a blood test.
MDedge Family Medicine
Investigational Drug Bests Exenatide in Glucose Control
MDedge Family Medicine